Control (n = 27) | Sepsis (n = 30) | ARDS (n = 47) | p-value | ||
---|---|---|---|---|---|
Age in years, median (IQR) | 62 (20) | 59 (31) | 55 (22) | 0.079 | |
BMI (Kg/m2), median (IQR) | 24.1 (3.68) | 25.7 (6.68) | 24.3 (6.03) | 0.310 | |
Sex, n (%) | |||||
Male | 12 (44.4%) | 10 (33.3%) | 24 (51.1%) | 0.311 | |
Female | 15 (55.6%) | 20 (66.7%) | 23 (48.9%) | ||
Self-declared Race, n (%) | |||||
White | 20 (74.1%) | 24 (80%) | 32 (68.1%) | 0.512 | |
Afro-descendent | 7 (25.9%) | 6 (20%) | 15 (31.9%) | ||
Comorbidities, n (%) | |||||
SAH | 20 (74.1%) | 19 (63.3%) | 20 (42.6%) | 0.021 | |
Cardiopathy | 12 (46.2%) | 8 (26.7%) | 5 (10.6%) | 0.003 | |
Vascular disease | 15 (57.7%) | 5 (16.7%) | 5 (10.6%) | < 0.0001 | |
Diabetes mellitus | 10 (37%) | 11 (36.7%) | 11 (23.4%) | 0.335 | |
Obesity | 4 (14.8%) | 7 (25.9%) | 4 (10.3%) | 0.229 | |
Hepatic disease | 4 (15.4%) | 8 (26.7%) | 9 (19.1%) | 0.556 | |
Neoplasia | 2 (7.4%) | 5 (16.7%) | 14 (29.8%) | 0.059 | |
Alcoholism | 2 (7.4%) | 3 (10%) | 6 (12.8%) | 0.770 | |
Chronic renal disease | 0 | 4 (13.3%) | 6 (15.8%) | 0.056 | |
Immunosuppression | 0 | 3 (10%) | 14 (29.8%) | 0.041 | |
Nervous system disease | 0 | 3 (10%) | 6 (15.8%) | 0.173 | |
Pulmonary Hypertension | 0 | 3 (10%) | 2 (4.3%) | 0.251 | |
HIV + | 0 | 1 (3.3%) | 3 (6.4%) | 0.383 | |
Period of hospitalization in days, median (IQR) | - | 7.5 (24) | 13 (14) | 0.101 | |
Mechanical ventilation duration in days, median (IQR) | - | 1 (2) | 3 (7) | < 0.0001 | |
Period of ICU stay in days, median (IQR) | - | 3.5 (7) | 5 (10) | 0.154 | |
SOFA score, median (IQR) | - | 15 (6) | 15 (4) | 0.961 | |
Lungs weight in grams, median (IQR) | - | 1026 (456) | 1575 (756) | < 0.0001 | |
Mechanical Ventilation, n (%) | - | 25 (83.3%) | 47 (100%) | 0.031 | |
FiO2 (%), median (IQR) | - | 100 (50)* | 90 (50) | 0.895 | |
PEEP (cmH2O), median (IQR) | - | 8 (5)** | 10 (6) | < 0.0001 | |
PaO2/FiO2 ratio, median (IQR) | - | 120.5 (136)*** | 95 (124) | 0.218 |